Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Laboratory Infrastructure Solutions
Street 1: 511-5 Freeman Str
Street 2: Midstream estate
City: Midrand
Province: Gauteng
Post Code: 1683
Country: South Africa
Phone: +27 82 733 5276
Email: info@startalab.co.za
Web Site: http://www.startalab.co.za

Focal Point Contact Information

Salutation: Mr
First Name: Johriaan
Last Name: de Beer
Title: Technical Director
Email: johriaan@startalab.co.za
Phone: +27 82 733 5276

Alternate Focal Point Contact Information

Salutation: Mr
First Name: Johriaan
Last Name: de Beer
Title:  
Email: info@startalab.co.za
Phone:  

General Information

Board Constituency: Private sector
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
Laboratory Infrastructure Solutions (LIS) specialises in the manufacturing and deployment of specilised medical infrastructure.

LIS brought to the market the containerized molecular laboratory, a bio safety level three (BSL3)laboratory ideally suited to TB prevalence surveys.

LIS plans to make its infrastructure, typically housed and transported in a shipping container to deployment sites all over the world.
 
Total number of staff in your organization: 1 - 5
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? Unable to disclose amount
How did you hear about the Stop TB Partnership: Involvement in TB control provision
Why do you wish join the Stop TB Partnership: Network with other partners
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
Our containerized infrastructure makes logistical and business sense and contributes to predictable service and optimal research quality.

These are the perspectives that LIS has opened up to you:
• LIS combines the implementation of quality laboratory systems with quality laboratory environments.
• LIS's rapid medical infrastructure is ideally suited to environments where normal construction processes and quality are unpredictable and costly. As with infrastructure risks, operational quality systems are often one of the biggest, but often most elusive, contributors to service failure. Our infrastructure solutions offers clean, ready made environments that deploys on minimal site preparation of services: plinth, water, electricity and drainage – we help you to plan the process.
 

Geographical Reach

Which country is your headquarters located in: South Africa
Which WHO region is the main focus of your work: Global
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Botswana
Haiti
Peru
South Africa
Zambia

Specializations

Delivery of health services and care
Technical Assistance

Specializations in Countries

Delivery of health services and care Haiti
Delivery of health services and care Peru
Delivery of health services and care South Africa
Delivery of health services and care Zambia
Technical Assistance Botswana

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Laboratory Strengthening:
Laboratory Infrastructure Solutions - manufactures containerized BSL3 laboratory, a safe, rapid deployment solution for areas which require reliable healthcare infrastructure.

New Diagnostics:
Our laboratory and other medical infrastructure solutions makes it possible to take new diagnostic technology to communities that need it most.

Declaration

Declaration of interests:
no conflict of interest

Application date: November 3, 2011
Last updated: February 23, 2013